The effects of laughter therapy on depression symptoms in patients undergoing center hemodialysis: A pragmatic randomized controlled trial.
Hemodialysis
anxiety
depression
end-stage kidney disease
laughter
Journal
Hemodialysis international. International Symposium on Home Hemodialysis
ISSN: 1542-4758
Titre abrégé: Hemodial Int
Pays: Canada
ID NLM: 101093910
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
30
12
2019
revised:
22
07
2020
accepted:
23
07
2020
pubmed:
28
8
2020
medline:
20
3
2021
entrez:
27
8
2020
Statut:
ppublish
Résumé
People with end-stage renal disease undergoing hemodialysis are at increased risk for stress, anxiety, and depression. The study objective was to measure the effect of intradialytic group laughter therapy on depressive symptoms in people on hemodialysis (HD). Pragmatic randomized controlled trial conducted with prevalent HD patients in 10 centers in Northern California. The intervention group received a once weekly, 30-minute group laughter therapy session for 8 weeks. Primary outcome was the number of people with depressive symptoms as measured using the four Item Patient Health Questionnaire. Secondary outcomes were anxiety, subjective well-being, and patient-reported outcome measures. In all, 151 participants completed both predepression and postdepression symptom measures (72 intervention and 79 control). The proportion of patients with self-reported depressive symptoms changed from 17 (22%) to 16 (20%), in the control and from 11 (17%) to 5 (8%) in the intervention arms, respectively (P = 0.04). In the control arm, 7 out of the 17 patients with self-reported depressive symptoms at baseline continued to report depressive symptoms at follow up compared to the intervention arm where only 1 of 12 patients continued to report depressive symptoms. No differences were noted between the groups for reported anxiety, patient-reported dialysis symptoms, and subjective well-being. This study found intradialytic group laughter can decrease the number of people with depressive symptoms receiving hemodialysis. Larger and long-term studies are required to evaluate the effect of intradialytic laughter on patient related outcomes and quality of life.
Types de publication
Journal Article
Pragmatic Clinical Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
541-549Informations de copyright
© 2020 International Society for Hemodialysis.
Références
Bujang MA, Musa R, Liu WJ, Chew TF, Lim CT, Morad Z. Depression, anxiety and stress among patients with dialysis and the association with quality of life. Asian J Psychiatr. 2015;18:49-52.
Chen SF, Wang IJ, Lang HC. Risk of major depression in patients with chronic renal failure on different treatment modalities: A matched-cohort and population-based study in Taiwan. Hemodial Int. 2016;20:98-105.
Lai AY, Loh AP, Mooppil N, Krishnan DS, Griva K. Starting on haemodialysis: A qualitative study to explore the experience and needs of incident patients. Psychol Health Med. 2012;17:674-684.
Rebollo Rubio A, Morales Asencio JM, Eugenia Pons Raventos M. Depression, anxiety and health-related quality of life amongst patients who are starting dialysis treatment. J Ren Care. 2017;43:73-82.
Chilcot J, Norton S, Wellsted D, Davenport A, Firth J, Farrington K. Distinct depression symptom trajectories over the first year of dialysis: Associations with illness perceptions. Ann Behav Med. 2013;45:78-88.
Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: Systematic review and meta-analysis of observational studies. Kidney Int. 2013;84:179-191.
Schouten RW, Haverkamp GL, Loosman WL, et al. Anxiety symptoms, mortality, and hospitalization in patients receiving maintenance dialysis: A cohort study. Am J Kidney Dis. 2019;74:158-166.
Taraz M, Taraz S, Dashti-Khavidaki S. Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: A review of literature. Hemodial Int. 2015;19:11-22.
Davenport A, Guirguis A, Almond M, et al. Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores. Hemodial Int. 2018;22:369-376.
Anand S, Johansen KL, Grimes B, et al. Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study. Hemodial Int. 2013;17:50-58.
Vasilopoulou C, Bourtsi E, Giaple S, Koutelekos I, Theofilou P, Polikandrioti M. The impact of anxiety and depression on the quality of life of hemodialysis patients. Glob J Health Sci. 2015;8:45-55.
Alosaimi FD, Asiri M, Alsuwayt S, et al. Psychosocial predictors of nonadherence to medical management among patients on maintenance dialysis. Int J Nephrol Renovasc Dis. 2016;9:263-272.
Mehrotra R, Cukor D, Unruh M, et al. Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: A randomized clinical trial. Ann Intern Med. 2019;170:369-379.
Palmer SC, Natale P, Ruospo M, et al. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. Cochrane Database Syst Rev. 2016;5:CD004541.
Cukor D, Ver Halen N, Asher DR, et al. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol. 2014;25:196-206.
Bennett PN, Ngo T, Kalife C, Schiller B. Improving wellbeing in patients undergoing dialysis: Can meditation help? Semin Dial. 2018;31:59-64.
Kouidi E, Karagiannis V, Grekas D, et al. Depression, heart rate variability, and exercise training in dialysis patients. Eur J Cardiovasc Prev Rehabil. 2010;17:160-167.
Hmwe NT, Subramanian P, Tan LP, Chong WK. The effects of acupressure on depression, anxiety and stress in patients with hemodialysis: A randomized controlled trial. Int J Nurs Stud. 2015;52:509-518.
Rodrigue JR, Mandelbrot DA, Pavlakis M. A psychological intervention to improve quality of life and reduce psychological distress in adults awaiting kidney transplantation. Nephrol Dial Transplant. 2011;26:709-715.
Öster I, Svensk A-C, Magnusson E, et al. Art therapy improves coping resources: A randomized, controlled study among women with breast cancer. Pall Supp Care. 2006;4:57-64.
Puig A, Lee SM, Goodwin L, Sherrard PA. The efficacy of creative arts therapies to enhance emotional expression, spirituality, and psychological well-being of newly diagnosed stage I and stage II breast cancer patients: A preliminary study. Arts Psychother. 2006;33:218-228.
Monti DA, Peterson C, Kunkel EJ, et al. A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psychooncology. 2006;15:363-373.
Hanser SB, Bauer-Wu S, Kubicek L, et al. Effects of a music therapy intervention on quality of life and distress in women with metastatic breast cancer. J Soc Integr Oncol. 2006;4:116-124.
Romito F, Lagattolla F, Costanzo C, Giotta F, Mattioli V. Music therapy and emotional expression during chemotherapy. How do breast cancer patients feel? Eur J Integ Med. 2013;5:438-442.
Hilliard RE. The effects of music therapy on the quality and length of life of people diagnosed with terminal cancer. J Music Ther. 2003;40:113-137.
Agboola SO, Ju W, Elfiky A, Kvedar JC, Jethwani K. The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: A systematic review of randomized controlled trials. J Med Internet Res. 2015;17:e65.
Bennett PN, Parsons T, Rea B-M. Intradialytic Laughter Yoga therapy for haemodialysis patients: A pre-post intervention feasibility study. BMC Compl Altern Med. 2015;15:176.
Cho EA, Oh HE. Effects of laughter therapy on depression, quality of life, resilience and immune responses in breast cancer survivors. J Korean Acad Nurs. 2011;41:285-293.
Walter M, Hanni B, Haug M, et al. Humour therapy in patients with late-life depression or Alzheimer's disease: A pilot study. Int J Geriatr Psychiatry. 2007;22:77-83.
Foley E, Matheis R, Schaefer C. Effect of forced laughter on mood. Psychol Rep. 2002;90:184.
De La Fuente Mochales MB, Gonzalez Cascante ME. Laughter therapy for chronic skeletal muscular pain. Rev Enferm. 2010;33:443-444.
Shahidi M, Mojtahed A, Modabbernia A, et al. Laughter yoga versus group exercise program in elderly depressed women: A randomized controlled trial. Int J Ger Psychiatry. 2011;26:322-327.
Brown A, Jeffrey C, Moyle D. Laughter yoga therapy in haemodialysis: One unit's experience. Ren Soc Australas J. 2019;15:38-46.
Bennett P, Kalife C, Luckett T, Cunanan J, Schiller B. Improving the dialysis patient experience through intradialytic laughter therapy. Nephrol News Issues. 2018;32:18-22.
Kataria M. Laughter Yoga International, 2019. Available from: https://laughteryoga.org/ (accessed date: May 18, 2020).
Gendry S. Laughter Online University, 2019. Available from: http://www.laughteronlineuniversity.com/ (accessed date: March 18, 2020).
Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics. 2009;50:613-621.
International Wellbeing Group. Personal Wellbeing Index. 4th ed. Melbourne, Australia: Australian Centre on Quality of Life, Deakin University, 2006.
Hutton VE, Misajon R, Collins FE. Subjective wellbeing and 'felt' stigma when living with HIV. Qual Life Res. 2013;22:65-73.
Bennett P, Weinberg M, Bridgman T, Cummins R. The happiness and subjective well-being of people on Haemodialysis. J Renal Care. 2015;41:156-161.
Pittman ZC, John SG, McIntyre CW. Collection of daily patient reported outcomes is feasible and demonstrates differential patient experience in chronic kidney disease. Hemodial Int. 2017;21:265-273.
Duggal V, Hussein WF, Reiterman M, Sun SJ, Abra GE, Schiller B. The effect of blood flow rate on dialysis recovery time in patients undergoing maintenance hemodialysis: A prospective, parallel-group, randomized controlled trial. Hemodial Int. 2019;23:223-229.
Bennett PN, Fraser S, Barnard R, et al. Effects of an intradialytic resistance training programme on physical function: A prospective stepped-wedge randomized controlled trial. Nephrol Dial Transplant. 2016;31:1302-1309.
Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ. 2008;337:a2390.
Bressington D, Mui J, Yu C, et al. Feasibility of a group-based laughter yoga intervention as an adjunctive treatment for residual symptoms of depression, anxiety and stress in people with depression. J Affect Disord. 2019;248:42-51.
Tanaka A, Tokuda N, Ichihara K. Psychological and physiological effects of laughter yoga sessions in Japan: A pilot study. Nurs Health Sci. 2018;20:304-312.
Dunbar RIM, Baron R, Frangou A, et al. Social laughter is correlated with an elevated pain threshold. Proc Royal Soc Biol Sc. 2012;279:1161-1167.
Bennett P, Parsons T, Ben-Moshe R, et al. Laughter and humor therapy in dialysis. Semin Dial. 2014;27:488-493.
Matsuzaki T, Nakajima A, Ishigami S, Tanno M, Yoshino S. Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45:182-186.
Satellite Healthcare. Laugh Out Loud Hemodialysis, 2019. Available from: http://www.satellitehealth.com/video-center/hemodialyisis/laugh-out-loud-hemodialysis/ (accessed date: May 18, 2020).